An Anti-MRSA Phage From Raw Fish Rinse: Stability Evaluation and Production Optimization

Israa M Abd-Allah1, Ghadir S El-Housseiny1, Mohammad Y Alshahrani2

  • 1Department of Microbiology and Immunology, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.

Insights

Researchers isolated bacteriophages effective against methicillin-resistant Staphylococcus aureus (MRSA). One phage, from fish rinse, showed broad activity and stability, indicating potential as an anti-MRSA therapeutic agent.

Area of Science:

  • Microbiology and Virology
  • Antimicrobial Resistance Research
  • Biotechnology and Pharmaceutical Development

Background:

  • Increasing antibiotic resistance in pathogens like methicillin-resistant Staphylococcus aureus (MRSA) necessitates novel therapeutic strategies.
  • Bacteriophages, natural predators of bacteria, are emerging as a promising alternative to conventional antibiotics.
  • The need for effective anti-MRSA agents is critical due to the rise of multidrug-resistant infections.

Purpose of the Study:

  • To isolate and characterize bacteriophages with potent lytic activity against MRSA.
  • To identify the bacteriophage with the broadest host range and optimize its production.
  • To evaluate the stability and potential pharmaceutical applications of the most effective anti-MRSA bacteriophage.

Main Methods:

  • Isolation of bacteriophages from environmental sources (egg rinses, milk, raw meat rinses).
  • Screening of isolated phages for lytic activity against 23 clinical MRSA isolates.
  • Characterization using electron microscopy, stability tests (pH, temperature, UV, solvents), and production optimization via response surface methodology.

Main Results:

  • Five phages were isolated, with one from raw fish rinse exhibiting activity against all tested MRSA isolates.
  • This broad-host-range phage, likely a Siphoviridae family member, demonstrated good thermal, pH, UV, and solvent stability.
  • Optimization of production conditions (pH 7, 0.5% sucrose, 0.1% peptone, 28°C, 10^7 CFU/ml inoculum) yielded a 2 log-fold increase in phage titer.

Conclusions:

  • A stable, broad-spectrum bacteriophage with significant lytic activity against MRSA was successfully isolated and characterized.
  • The phage's stability under various conditions suggests its potential as a viable therapeutic agent for MRSA infections.
  • Bacteriophage therapy represents a promising strategy to combat multidrug-resistant pathogens like MRSA.